[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-464594-105":59,"doc-detail-464594-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","single-cell-transcriptomic-profiling-reveals-that-macrophage-induced-angiogenesis-contributes-to-immunotherapy-resistance-in-hepatocellular-carcinoma","Single-Cell Transcriptomic Profiling Reveals That Macrophage-Induced Angiogenesis Contributes to Immunotherapy Resistance in Hepatocellular Carcinoma","","Hepatocellular carcinoma (HCC) has a complex tumor microenvironment that often undermines immunotherapy, especially PD-1/PD-L1 checkpoint blockade. This study identifies a distinct NFKBIZ+ M0 macrophage subset enriched in patients non-responsive to anti-PD-1 therapy. Single-cell transcriptomic profiling shows hypoxia-driven secretion of VEGFA and HBEGF that promotes tumor angiogenesis, together with increased CXCL2, CXCL3, and CXCL8 supporting an immunosuppressive, pro-tumorigenic state. Network analysis highlights FOSB–VEGFA and FOS–HBEGF as key regulatory axes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/single-cell-transcriptomic-profiling-reveals-that-macrophage-induced-angiogenesis-contributes-to-immunotherapy-resistance-in-hepatocellular-carcinoma/464594/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/single-cell-transcriptomic-profiling-reveals-that-macrophage-induced-angiogenesis-contributes-to-immunotherapy-resistance-in-hepatocellular-carcinoma/464594.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which macrophage subset is linked to anti-PD-1 non-response in HCC?","Question",{"text":112,"@type":113},"The study identifies an NFKBIZ+ M0 macrophage subset that is predominantly present in non-responders to anti-PD-1 treatment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do these macrophages promote treatment resistance?",{"text":117,"@type":113},"They adopt a hypoxia-induced phenotype that secretes VEGFA and HBEGF to enhance angiogenesis and increases inflammatory chemokines (CXCL2, CXCL3, CXCL8) to build an immunosuppressive microenvironment.",{"name":119,"@type":110,"acceptedAnswer":120},"What signaling regulatory axes are identified as key drivers?",{"text":121,"@type":113},"Transcriptional regulatory network analysis points to FOSB–VEGFA and FOS–HBEGF axes as key drivers of the pathogenic macrophage phenotype.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},464594,1791155854,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article  \nSingle-Cell Transcriptomic Profiling Reveals That MacrophageInduced Angiogenesis Contributes to Immunotherapy Resistance in Hepatocellular Carcinoma  \nXinyu Pan 1,†, Baolin Liao 2,3,†, Zhijie Hu 2,3, * and Yuanyan Xiong 1, *  \nAcademic Editor: Hang Fai (Henry) Kwok  \nReceived: 14 November 2025  \nRevised: 19 December 2025  \nAccepted: 30 December 2025  \nPublished: 2 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Key Laboratory of Gene Engineering of the Ministry of Education, Department of Biochemistry, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China; [merakp0029@gmail.com](merakp0029@gmail.com)  \n2 Department of Hepatology, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou 510440, China; [polinlbl@163.com](polinlbl@163.com)  \n3 Guangzhou Key Laboratory of Clinical Pathogen Research for Infectious Diseases, Guangzhou 510440, China  \n* [Correspondence: huzhj7@gzhmu.edu.cn](Correspondence: huzhj7@gzhmu.edu.cn) (Z.H.); [xyyan@mail.sysu.edu.cn](xyyan@mail.sysu.edu.cn) (Y.X.)† These authors contributed equally to this work.  \nSimple Summary  \nHepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide, and many patients do not respond well to immunotherapy. In this study, we identified a unique group of macrophages—called NFKBIZ+ M0 macrophages—that are enriched in patients non-responsive to anti-PD-1 treatment. These macrophages are activated by hypoxia and release factors such as VEGFA and HBEGF that promote new blood vessel formation and tumor growth. They also produce inflammatory molecules that suppress the immune system, helping the tumor evade immune attack. Further analysis revealed that specific signaling pathways (FOSB–VEGFA and FOS–HBEGF) drive this harmful macrophage behavior. Our findings uncover a new mechanism linking hypoxia, angiogenesis, and immune evasion to treatment resistance in HCC and suggest potential therapeutic targets to improve immunotherapy outcomes.  \nAbstract  \nHepatocellular carcinoma (HCC) ranks among the top causes of cancer-related mortality worldwide, and its complex tumor microenvironment (TME) contributes to poor responses to immunotherapy. Although PD-1/PD-L1 blockade has emerged as an effective treatment strategy, therapeutic resistance frequently limits its clinical benefit. Here, we uncover a distinct macrophage population associated with anti-PD-1 resistance in HCC. Single-cell transcriptomic profiling reveals an NFKBIZ+ M0 macrophage subset predominantly present in non-responders. Notably, these macrophages exhibit a hypoxia-induced phenotype characterized by the secretion of VEGFA and HBEGF, which cooperatively enhance tumor angiogenesis, alongside an elevated expression of the inflammatory chemokines CXCL2, CXCL3, and CXCL8 that consolidate an immunosuppressive, pro-tumorigenic microenvironment. Transcriptional regulatory network analysis further identified FOSB–VEGFA and FOS–HBEGF axes as key drivers of this pathogenic macrophage phenotype. Our findings define a distinct NFKBIZ+ macrophage population that mechanistically links hypoxia, angiogenesis, and immune evasion to PD-1 blockade resistance. This work provides new insights into the cellular and molecular basis of immunotherapy failure in HCC and highlights potential targets for overcoming treatment resistance.  \nKeywords: hepatocellular carcinoma; immune checkpoint blockade; M0 macrophages; tumor angiogenesis; transcriptional regulation  \n1. Introduction  \nHepatocellular carcinoma (HCC) is the sixth most common malignancy and the third leading cause of cancer-related death worldwide [1] . Its pathogenesis is intricately linked to chronic liver disorders, such as viral hepatitis, alcoholic liver disease, and metabolicassociated fatty liver disease [1–3] . Substantia","cbCaitlF2ZT9XkpO","https://ap.wps.com/l/cbCaitlF2ZT9XkpO","pdf",12420805,18,"English","# Introduction\n## PD-1/PD-L1 checkpoint blockade and resistance\n## Tumor angiogenesis and hypoxia signaling\n## Tumor microenvironment determinants of ICB efficacy","[{\"question\":\"Which macrophage subset is linked to anti-PD-1 non-response in HCC?\",\"answer\":\"The study identifies an NFKBIZ+ M0 macrophage subset that is predominantly present in non-responders to anti-PD-1 treatment.\"},{\"question\":\"How do these macrophages promote treatment resistance?\",\"answer\":\"They adopt a hypoxia-induced phenotype that secretes VEGFA and HBEGF to enhance angiogenesis and increases inflammatory chemokines (CXCL2, CXCL3, CXCL8) to build an immunosuppressive microenvironment.\"},{\"question\":\"What signaling regulatory axes are identified as key drivers?\",\"answer\":\"Transcriptional regulatory network analysis points to FOSB–VEGFA and FOS–HBEGF axes as key drivers of the pathogenic macrophage phenotype.\"}]","Single-Cell Transcriptomic Profiling Reveals That Macrophage-Induced Angiogenesis Contributes to Immunotherapy Resistance in Hepatocellular Carcinoma | PDF",1790768391,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/de7b2517b957353f48abb37d996b24f2.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/23e82bf7d12bfd71969879abfcfb0cdc.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/996728e7c00a4a4b147e6777fefb2801.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/ddb7b40f5ac9a1f9e6f970d389497dc6.webp",980,1385]